In vivo magnetic resonance measures of dark cytotoxicity of photosensitizers in a murine tumor model

S. Ramaprasad, E. Ripp, J. Pi, Shantaram S Joshi, S. K. Pandey, J. Missert, R. K. Pandey

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Photodynamic therapy (PDT) is a novel cancer treatment modality where the therapeutic action is controlled by light and the potency of the photosensitizer used. Development of new potent photosensitizers (PS) for clinical applications requires that the PDT effects are maximized while minimizing dark cytotoxicity. The dark toxicity of photosensitizers is generally confirmed using cell lines. Photososensitizers that appear promising from in vitro assays need further investigations under in vivo conditions. As in vivo MR methods have the potential to provide information on the tumor status, they can be very effective tools to study dark toxicity of tumors. The tumor produced on the mouse foot dorsum was tested on two newly synthesized photosensitizers along with Photofrin as a control. The MR studies consisted of serial 31P spectral measurements both before and after PS injection. The results show significant changes in the tumor metabolism with increased inorganic phosphate while using new photosensitizers. However these changes slowly approached control levels several hours later. The studies performed while using Photofrin did not show any significant changes indicating minimal or no dark cytotoxicity. Similar studies performed on normal tissue such as the muscle indicated that the energy metabolism was minimally compromised. Our studies demonstrate that the effects of dark cytotoxicity can be observed by 31P MR. The growth profiles of tumors treated with PS alone indicate that the metabolic changes are temporary and do not interfere with the tumor growth. The studies suggest that MR is a new method of monitoring the effect of PS administered toxicity in an in vivo model.

Original languageEnglish (US)
Title of host publicationProgress in Biomedical Optics and Imaging - Proceedings of SPIE
EditorsA.A. Amini, A. Manduca
Pages16-22
Number of pages7
Volume5746
EditionI
DOIs
StatePublished - 2005
EventMedical Imaging 2005 - Physiology, Function, and Structure from Medical Images - San Diego, CA, United States
Duration: Feb 13 2005Feb 15 2005

Other

OtherMedical Imaging 2005 - Physiology, Function, and Structure from Medical Images
CountryUnited States
CitySan Diego, CA
Period2/13/052/15/05

Fingerprint

Photosensitizers
Magnetic resonance
Cytotoxicity
Tumors
Toxicity
Photodynamic therapy
Oncology
Level control
Metabolism
Muscle
Assays
Phosphates
Cells
Tissue
Monitoring

Keywords

  • P MR
  • Dark cytotoxicity
  • Magnetic Resonance Spectroscopy
  • Photodynamic therapy
  • RF coils
  • RIF tumor
  • Tumor Growth Profiles

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Ramaprasad, S., Ripp, E., Pi, J., Joshi, S. S., Pandey, S. K., Missert, J., & Pandey, R. K. (2005). In vivo magnetic resonance measures of dark cytotoxicity of photosensitizers in a murine tumor model. In A. A. Amini, & A. Manduca (Eds.), Progress in Biomedical Optics and Imaging - Proceedings of SPIE (I ed., Vol. 5746, pp. 16-22). [03] https://doi.org/10.1117/12.593798

In vivo magnetic resonance measures of dark cytotoxicity of photosensitizers in a murine tumor model. / Ramaprasad, S.; Ripp, E.; Pi, J.; Joshi, Shantaram S; Pandey, S. K.; Missert, J.; Pandey, R. K.

Progress in Biomedical Optics and Imaging - Proceedings of SPIE. ed. / A.A. Amini; A. Manduca. Vol. 5746 I. ed. 2005. p. 16-22 03.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ramaprasad, S, Ripp, E, Pi, J, Joshi, SS, Pandey, SK, Missert, J & Pandey, RK 2005, In vivo magnetic resonance measures of dark cytotoxicity of photosensitizers in a murine tumor model. in AA Amini & A Manduca (eds), Progress in Biomedical Optics and Imaging - Proceedings of SPIE. I edn, vol. 5746, 03, pp. 16-22, Medical Imaging 2005 - Physiology, Function, and Structure from Medical Images, San Diego, CA, United States, 2/13/05. https://doi.org/10.1117/12.593798
Ramaprasad S, Ripp E, Pi J, Joshi SS, Pandey SK, Missert J et al. In vivo magnetic resonance measures of dark cytotoxicity of photosensitizers in a murine tumor model. In Amini AA, Manduca A, editors, Progress in Biomedical Optics and Imaging - Proceedings of SPIE. I ed. Vol. 5746. 2005. p. 16-22. 03 https://doi.org/10.1117/12.593798
Ramaprasad, S. ; Ripp, E. ; Pi, J. ; Joshi, Shantaram S ; Pandey, S. K. ; Missert, J. ; Pandey, R. K. / In vivo magnetic resonance measures of dark cytotoxicity of photosensitizers in a murine tumor model. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. editor / A.A. Amini ; A. Manduca. Vol. 5746 I. ed. 2005. pp. 16-22
@inproceedings{63d089478a414fb6b94b0d6e76f31e6a,
title = "In vivo magnetic resonance measures of dark cytotoxicity of photosensitizers in a murine tumor model",
abstract = "Photodynamic therapy (PDT) is a novel cancer treatment modality where the therapeutic action is controlled by light and the potency of the photosensitizer used. Development of new potent photosensitizers (PS) for clinical applications requires that the PDT effects are maximized while minimizing dark cytotoxicity. The dark toxicity of photosensitizers is generally confirmed using cell lines. Photososensitizers that appear promising from in vitro assays need further investigations under in vivo conditions. As in vivo MR methods have the potential to provide information on the tumor status, they can be very effective tools to study dark toxicity of tumors. The tumor produced on the mouse foot dorsum was tested on two newly synthesized photosensitizers along with Photofrin as a control. The MR studies consisted of serial 31P spectral measurements both before and after PS injection. The results show significant changes in the tumor metabolism with increased inorganic phosphate while using new photosensitizers. However these changes slowly approached control levels several hours later. The studies performed while using Photofrin did not show any significant changes indicating minimal or no dark cytotoxicity. Similar studies performed on normal tissue such as the muscle indicated that the energy metabolism was minimally compromised. Our studies demonstrate that the effects of dark cytotoxicity can be observed by 31P MR. The growth profiles of tumors treated with PS alone indicate that the metabolic changes are temporary and do not interfere with the tumor growth. The studies suggest that MR is a new method of monitoring the effect of PS administered toxicity in an in vivo model.",
keywords = "P MR, Dark cytotoxicity, Magnetic Resonance Spectroscopy, Photodynamic therapy, RF coils, RIF tumor, Tumor Growth Profiles",
author = "S. Ramaprasad and E. Ripp and J. Pi and Joshi, {Shantaram S} and Pandey, {S. K.} and J. Missert and Pandey, {R. K.}",
year = "2005",
doi = "10.1117/12.593798",
language = "English (US)",
volume = "5746",
pages = "16--22",
editor = "A.A. Amini and A. Manduca",
booktitle = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",
edition = "I",

}

TY - GEN

T1 - In vivo magnetic resonance measures of dark cytotoxicity of photosensitizers in a murine tumor model

AU - Ramaprasad, S.

AU - Ripp, E.

AU - Pi, J.

AU - Joshi, Shantaram S

AU - Pandey, S. K.

AU - Missert, J.

AU - Pandey, R. K.

PY - 2005

Y1 - 2005

N2 - Photodynamic therapy (PDT) is a novel cancer treatment modality where the therapeutic action is controlled by light and the potency of the photosensitizer used. Development of new potent photosensitizers (PS) for clinical applications requires that the PDT effects are maximized while minimizing dark cytotoxicity. The dark toxicity of photosensitizers is generally confirmed using cell lines. Photososensitizers that appear promising from in vitro assays need further investigations under in vivo conditions. As in vivo MR methods have the potential to provide information on the tumor status, they can be very effective tools to study dark toxicity of tumors. The tumor produced on the mouse foot dorsum was tested on two newly synthesized photosensitizers along with Photofrin as a control. The MR studies consisted of serial 31P spectral measurements both before and after PS injection. The results show significant changes in the tumor metabolism with increased inorganic phosphate while using new photosensitizers. However these changes slowly approached control levels several hours later. The studies performed while using Photofrin did not show any significant changes indicating minimal or no dark cytotoxicity. Similar studies performed on normal tissue such as the muscle indicated that the energy metabolism was minimally compromised. Our studies demonstrate that the effects of dark cytotoxicity can be observed by 31P MR. The growth profiles of tumors treated with PS alone indicate that the metabolic changes are temporary and do not interfere with the tumor growth. The studies suggest that MR is a new method of monitoring the effect of PS administered toxicity in an in vivo model.

AB - Photodynamic therapy (PDT) is a novel cancer treatment modality where the therapeutic action is controlled by light and the potency of the photosensitizer used. Development of new potent photosensitizers (PS) for clinical applications requires that the PDT effects are maximized while minimizing dark cytotoxicity. The dark toxicity of photosensitizers is generally confirmed using cell lines. Photososensitizers that appear promising from in vitro assays need further investigations under in vivo conditions. As in vivo MR methods have the potential to provide information on the tumor status, they can be very effective tools to study dark toxicity of tumors. The tumor produced on the mouse foot dorsum was tested on two newly synthesized photosensitizers along with Photofrin as a control. The MR studies consisted of serial 31P spectral measurements both before and after PS injection. The results show significant changes in the tumor metabolism with increased inorganic phosphate while using new photosensitizers. However these changes slowly approached control levels several hours later. The studies performed while using Photofrin did not show any significant changes indicating minimal or no dark cytotoxicity. Similar studies performed on normal tissue such as the muscle indicated that the energy metabolism was minimally compromised. Our studies demonstrate that the effects of dark cytotoxicity can be observed by 31P MR. The growth profiles of tumors treated with PS alone indicate that the metabolic changes are temporary and do not interfere with the tumor growth. The studies suggest that MR is a new method of monitoring the effect of PS administered toxicity in an in vivo model.

KW - P MR

KW - Dark cytotoxicity

KW - Magnetic Resonance Spectroscopy

KW - Photodynamic therapy

KW - RF coils

KW - RIF tumor

KW - Tumor Growth Profiles

UR - http://www.scopus.com/inward/record.url?scp=23844558894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844558894&partnerID=8YFLogxK

U2 - 10.1117/12.593798

DO - 10.1117/12.593798

M3 - Conference contribution

VL - 5746

SP - 16

EP - 22

BT - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

A2 - Amini, A.A.

A2 - Manduca, A.

ER -